Shattuck Labs, Inc.
COMBINATION THERAPIES COMPRISING SIRP ALPHA-BASED CHIMERIC PROTEINS

Last updated:

Abstract:

The present invention relates to, inter alia, combinations of compositions which include chimeric proteins that find use in methods for treating disease, such as immunotherapies for cancer and autoimmunity.

Status:
Application
Type:

Utility

Filling date:

29 Aug 2019

Issue date:

9 Dec 2021